GLP-1 Weight-Loss Drugs May Reduce Everyday Physical Activity
Summary: Researchers identified a crucial behavioral paradox in contemporary weight management: adults taking glucagon-like peptide-1 (GLP-1) receptor agonists show a measurable decline in daily physical activity, despite losing weight. Using passive wearable sensor data from the National Institutes of Health (NIH) All of Us Research Program, investigators combined Fitbit activity records with linked electronic health … Read more